Other languages Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:35 2024-06-07 am EDT			5-day change	1st Jan Change
984 ^DKK	+1.10%		+6.11%	+40.95%

Jun. 06	Novo Nordisk braces for Ozempic rivals in China	RE
Jun. 06	European equities gain on tech boost in run-up to ECB	RE

Aktien New York Schluss: Weitere Rekorde ohne viel Bewegung	Jun. 07
AKTIEN IM FOKUS 2/Abnehm-Boom: Rally bei Eli Lilly und Novo Nordisk geht weiter	Jun. 07
ASML nach Rekordhoch weiter gefragt - LVMH überholt	Jun. 07
Novo Nordisk bekommt in China Konkurrenz für Ozempic	Jun. 06
Vers l'infini et au-delà	Jun. 06
European equities gain on tech boost in run-up to ECB	Jun. 06
Borsa di Italia: Verso l'infinito e oltre	Jun. 06
IN DIRETTA DAI MERCATI: Diasorin, Finecobank, Unicredit, Generali, Stellantis, Poste Italiane, TIM, Novo Nordisk, Nvidia, Lululemon...	Jun. 06
Bolsa de Madrid: Hasta el infinito y más allá	Jun. 06
Novo Nordisk Faces Competition in China for Key Ingredient in Diabetes, Weight Loss Drug	Jun. 06
Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic	Jun. 05
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China	Jun. 05
UK Stocks-Factors to watch on June 6	Jun. 05
UK Institute Makes Draft Recommendation for Eli Lilly's Weight-loss Drug With No Time Limit	Jun. 05
Britain considers offering Lilly weight-loss drug on better terms than Wegovy	Jun. 04
Adocia : un directeur des opérations nommé	Jun. 04
Structure Therapeutics' obesity drug meets main goal in mid-stage study	Jun. 03
JPMorgan European G&I raises dividend after outperforming benchmark	Jun. 03
Zealand Pharma Secures EU Panel Backing for Severe Hypoglycemia Treatment	May. 31
Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs	May. 30